Nifedipine
- Product NDC
- 68071-3287
- 11-digit product format
- 680713287
- Labeler code
- 68071
- Product ID
- 68071-3287_5033e600-1b2e-1a91-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nifedipine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA075269
- Marketing category
- ANDA
- Marketing start
- 2012-10-18
- Marketing end
- 0000-00-00
- Substance
- NIFEDIPINE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-3287-3 | 2020-05-13 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |
| 68071-3287-5 | 2020-05-13 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |
| 68071-3287-6 | 2020-05-13 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |
| 68071-3287-9 | 2020-05-13 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |
| 68071-3287-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |
| 68071-3287-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |
| 68071-3287-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |
| 68071-3287-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-af12-f424-e053-dadaa90a57ce | 5033e600-1b2d-1a91-e054-00144ff8d46c |